News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website


Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 There was a lot of research on Optune presented last week at the SNO meeting!   You can see the list of abstracts when you click the link below.. the abstracts are available on the Neuro-oncology website at https://academic.oup.com/neuro-oncology/issue/21/Supplement_6   you can search for the abstract number from the list of presentations, but note they reuse the abstract numbers from year to year so when you search for a presentation, you get a list of results.  Look for the year 2019!

highlights:

Using Optune at the same time as radiation is now possible.  Too early to report results but it was safe.

 Adding Celebrex or a checkpoint inhibitor or Avastin or Lomustine  to Optune helps somewhat!  We need to find the best combinations.

 

 


Posted on: 11/25/2019

Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740